Literature DB >> 28925903

Regulation of Clusterin Gene Expression.

Marilina Garcia-Aranda1, Alfonso Serrano2, Maximino Redondo1.   

Abstract

Clusterin is a multifunctional glycoprotein whose role in cells has generated a great controversy in recent years. Since its discovery, numerous studies have linked clusterin expression deregulation with various physio-pathological processes such as cancer or Alzheimer's disease. Although the results of such investigations have sometimes been contradictory, mainly due to the dichotomous role of clusterin isoforms, it has been demonstrated that this protein is involved in diverse cellular processes, including apoptosis, cell cycle regulation, DNA repair or the acquisition of cell resistance against multiple conventional therapies. These results, together with the breakthrough of gene therapies, have motivated a great effort to elucidate the importance of clusterin as a potential therapeutic target. However, the understanding of a single gene, with multiple RNA transcripts and several protein isoforms has turned out to be a complex task. In this review, we summarize the studies published to date on factors that can affect clusterin expression and evaluate if a better understanding of this complex gene/protein would be useful to develop new treatment strategies for cancer and other pathologies. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer's disease; Clusterin; cancer; epigenetic; gene; regulation; transcription factor.

Mesh:

Substances:

Year:  2018        PMID: 28925903     DOI: 10.2174/1389203718666170918155247

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  6 in total

1.  Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis.

Authors:  Shaobo Huang; Xu Li; Weiqi Gu; Xiaoyi Li; Jingjing Zhao; Jueheng Wu; Junchao Cai; Xianming Feng; Tianyu Tao
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

2.  Clusterin as a potential marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy.

Authors:  Joanna Iłżecka; Marek Iłżecki; Aneta Grabarska; Shawn Dave; Marcin Feldo; Tomasz Zubilewicz
Journal:  Ups J Med Sci       Date:  2019-08-28       Impact factor: 2.384

3.  Clusterin is involved in mediating the metabolic function of adipose SIRT1.

Authors:  Pengcheng Zhang; Daniels Konja; Yiwei Zhang; Aimin Xu; In-Kyu Lee; Jae-Han Jeon; Ghader Bashiri; Alok Mitra; Yu Wang
Journal:  iScience       Date:  2021-12-29

4.  Deregulated Clusterin as a Marker of Bone Fragility: New Insights into the Pathophysiology of Osteoporosis.

Authors:  Virginia Veronica Visconti; Chiara Greggi; Ida Cariati; Beatrice Gasperini; Ambra Mastrogregori; Annalisa Botta; Umberto Tarantino
Journal:  Genes (Basel)       Date:  2022-04-07       Impact factor: 4.141

Review 5.  Immunotherapy: A Challenge of Breast Cancer Treatment.

Authors:  Marilina García-Aranda; Maximino Redondo
Journal:  Cancers (Basel)       Date:  2019-11-20       Impact factor: 6.639

Review 6.  Secreted Chaperones in Neurodegeneration.

Authors:  Kriti Chaplot; Timothy S Jarvela; Iris Lindberg
Journal:  Front Aging Neurosci       Date:  2020-08-27       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.